Back to News
Market Impact: 0.25

MDT Factor-Based Stock Analysis

MDTNDAQ
Company FundamentalsAnalyst InsightsDerivatives & VolatilityCapital Returns (Dividends / Buybacks)Healthcare & BiotechMarket Technicals & Flows
MDT Factor-Based Stock Analysis

Validea's guru fundamental report indicates MEDTRONIC PLC (MDT) scores 68% using the Pim van Vliet Multi-Factor Investor model, which prioritizes low volatility, strong momentum, and high net payout yields. While MDT passed market capitalization and standard deviation criteria, it registered as neutral for twelve-minus-one momentum and net payout yield, resulting in a "FAIL" on the model's final rank. This 68% score falls below the 80% threshold for typical interest, suggesting limited conviction in MDT based on its underlying fundamentals and valuation within this specific factor strategy.

Analysis

According to a Validea fundamental report, Medtronic plc (MDT) scores a 68% using the Pim van Vliet Multi-Factor Investor model, a rating that falls below the 80% threshold typically indicating strategic interest. The analysis reveals a mixed factor profile for the large-cap medical device company. While MDT passes the model's criteria for low-risk attributes, specifically market capitalization and standard deviation, it fails to generate a positive signal on other key factors. The stock is rated as "NEUTRAL" on both its "twelve minus one momentum" and its "net payout yield." This combination of passing on volatility but faltering on momentum and yield leads to an ultimate "FAIL" on the model's final rank, suggesting that for investors seeking a confluence of low risk, strong momentum, and high shareholder yield, MDT's current profile is suboptimal.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo